In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...

GMED opened at $73.67 on Friday. The stock has a market capitalization of $10.13 billion, a price-to-earnings ratio of 98.22, a PEG ratio of 1.61 and a beta of 1.19. The company has a fifty day ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) on April 15 and set a price target of $101.00. Discover outperforming stocks and invest ...